Variants in the HEPSIN gene are associated with susceptibility to prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 15, Issue 4, 2012, Pages 353-358

  Kim, H J ^a   Han, J H ^b   Chang, I H ^a   Kim, W ^a   Myung, S C ^a  

^a Chung Ang University College of Medicine   (South Korea)

^b Korea Electric Power Research Institute (KEPRI)   (South Korea)

Author keywords

cancer risk; hepsin; polymorphism

Indexed keywords

HEPSIN;

3' UNTRANSLATED REGION; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLEASON SCORE; HAPLOTYPE; HEPSIN GENE; HUMAN; INTRON; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS; SERINE ENDOPEPTIDASES;

EID: 84869217153     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2012.17     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Park SK, Sakoda LC, Kang D, Chokkalingam AP, Lee E, Shin HR et al. Rising prostate cancer rates in South Korea. Prostate 2006; 66: 1285-1291. (Pubitemid 44384305)
3. Chan JM, Holick CN, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ et al. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control 2006; 17: 199-208. (Pubitemid 43121769)
4. Naylor SL. SNPs associated with prostate cancer risk and prognosis. Front Biosci 2007; 12: 4111-4131.
5. Wu Q, Parry G. Hepsin and prostate cancer. Front Biosci 2007; 12: 5052-5059.
6. Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA et al. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 2001; 61: 5692-5696. (Pubitemid 32769078)
7. Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristiansen G et al. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. J Urol 2004; 171: 187-191. (Pubitemid 37549120)
8. Chen Z, Fan Z, McNeal JE, Nolly R, Caldwell MC, Mahadevappa M et al. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. J Urol 2003; 169: 1316-1319. (Pubitemid 36323775)
9. Klezovitch O, Chevillet J, Mirosevich J, Roberts RL, Matusik RJ, Vasioukhin V. Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 2004; 6: 185-195. (Pubitemid 39485690)
10. Vasioukhin V. Hepsin paradox reveals unexpected complexity of metastatic process. Cell Cycle 2004; 3: 1394-1397. (Pubitemid 40310675)
11. Xuan JA, Schneider D, Toy P, Lin R, Newton A, Zhu Y et al. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture. Cancer Res 2006; 66: 3611-3619.
12. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412: 822-826. (Pubitemid 32801464)
13. Witte JS, Goddard KA, Conti DV, Elston RC, Lin J, Suarez BK et al. Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet 2000; 67: 92-99. (Pubitemid 30481547)
14. Witte JS, Suarez BK, Thiel B, Lin J, Yu A, Banerjee TK et al. Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate 2003; 57: 298-308. (Pubitemid 37487075)
15. Pal P, Xi H, Kaushal R, Sun G, Jin CH, Jin L et al. Variants in the HEPSIN gene are associated with prostate cancer in men of European origin. Hum Genet 2006; 120: 187-192. (Pubitemid 44204007)
16. Song SY, Kim SR, Ahn G, Choi HY. Pathologic characteristics of prostatic adenocarcinomas: a mapping analysis of Korean patients. Prostate Cancer Prostatic Dis 2003; 6: 143-147. (Pubitemid 36798382)
17. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotech Suppl 2002; 56-8: 60-61.
18. Morris JA, Gardner MJ. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J 1988; 296: 1313-1316.
19. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117: 331-341.
20. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989. (Pubitemid 32289743)
21. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769. (Pubitemid 38420107)
22. Lewis CM. Genetic association studies: design, analysis and interpretation. Brief Bioinform 2002; 3: 146-153.
23. Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 2002; 62: 4427-4433. (Pubitemid 34827303)
24. Stamey TA, Warrington JA, Caldwell MC, Chen Z, Fan Z, Mahadevappa M et al. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 2001; 166: 2171-2177. (Pubitemid 33065250)
25. Neville PJ, Conti DV, Krumroy LM, Catalona WJ, Suarez BK, Witte JS et al. Prostate cancer aggressiveness locus on chromosome segment 19q12-q13. identified by linkage and allelic imbalance studies. Genes Chromosomes Cancer 2003; 36: 332-339. (Pubitemid 36314516)
26. Burmester JK, Suarez BK, Lin JH, Jin CH, Miller RD, Zhang KQ et al. Analysis of candidate genes for prostate cancer. Hum Hered 2004; 57: 172-178. (Pubitemid 39664083)
27. Holt SK, Kwon EM, Lin DW, Ostrander EA, Stanford JL. Association of hepsin gene variants with prostate cancer risk and prognosis. Prostate 2010; 70: 1012-1019.
28. Kim DK, Kim SJ, Moon HS, Park SY, Kim YT, Choi HY et al. The role of TURP in the detection of prostate cancer in BPH patients with previously negative prostate biopsy. Korean J Urol 2010; 51: 313-317.